Active, Not Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 Conditions Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States View all 1007 locations View more locations Show fewer locations Loading locations... View Trial Details
